Berman Capital Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $5K | Buy |
50
+20
| +67% | +$2K | ﹤0.01% | 1450 |
|
|
2021
Q2 | $3K | Buy |
30
+21
| +233% | +$2.1K | ﹤0.01% | 1536 |
|
|
2021
Q1 | $0 | Buy |
+9
| New | – | ﹤0.01% | 1964 |
|
|
2020
Q4 | – | Sell |
-7
| Closed | – | – | 1884 |
|
|
2020
Q3 | $0 | Hold |
7
| – | – | ﹤0.01% | 1831 |
|
|
2020
Q2 | $1K | Buy |
+7
| New | +$1K | ﹤0.01% | 1547 |
|